ACE inhibitor renal monitoring — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Withhold supply pending urgent prescriber review of renal function and potassium
ACE inhibitors can cause a rise in creatinine and potassium after initiation or dose increase. A significant creatinine rise with potassium 5.7 mmol/L requires prompt clinical review before continuing the higher dose. Dietary advice alone is insufficient and spironolactone would worsen hyperkalaemia risk.
Reference: BNF; NICE CKS